iqvia semaglutide tirzepatide prescriptions q3 2024 GLP-1 Weight Loss Drug Market Size, Share This Week in GLP-1: Apotex

GLP-1 administration does not require patients to have cleared opioids from their system to initiate treatment for OUD and does not precipitate withdrawal when administered

Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis

A study published by the Cleveland Clinic in June 2025 showed that real world outcomes did not match clinical trials largely because of early discontinuation and non-persistence

Mercers survey indicated that some employers chose to enhance key benefits by adding GLP-1 coverage even as overall health costs rose modestly ( [28] )